Mobile-health Network Solutions

As previously disclosed, at the Company’s Extraordinary General Meeting held on June 8, 2026, the Company’s shareholders approved, among other items, (i) the 1-for-6 reverse stock split of all of its issued and outstanding, and authorized but unissued, ordinary shares (the “Reverse Stock Split”), (ii) an increase in the authorised share capital of the Company (the “Increase in Authorised Share Capital”), and (iii) the Amended and Restated Memorandum and Articles of Association of the Company (the “Memorandum Amendment”) to reflect the Reverse Stock Split and Increase in Authorised Share Capital.

On June 10, 2026, the Company’s Board of Directors, acting pursuant to the approval by the Company’s shareholders, filed the Memorandum Amendment by sending notice to the Registrar of Companies of the Cayman Islands.

Pursuant to the Memorandum Amendment, the authorised share capital has been changed to $18,720,000 and is now divided into 19,500,000,000 ordinary shares, and the par value of the ordinary shares has increased from $0.00016 per share to $0.00096 per share. As a result of the Reverse Stock Split, every six issued and outstanding ordinary shares were combined into one issued and outstanding ordinary share. Shareholders will not receive fractional shares; instead, any fractional entitlement will be rounded up such that each Shareholder shall receive one ordinary share in lieu of any fractional shares.

The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on June 29, 2026, and the Company’s ordinary shares will begin trading on a Reverse Stock Split-adjusted basis on the Nasdaq Capital Market under the existing ticker symbol “MNDR” at the market open on June 29, 2026. The Company had previously announced that the Reverse Stock Split was expected to become effective on June 22, 2026, however the effective date has been postponed to June 29, 2026.

After the Reverse Stock Split, the trading symbol for the Company’s ordinary shares will continue to be “MNDR.” The new CUSIP number for the Company’s ordinary shares is G62264 133.

The foregoing description of the Memorandum Amendment is a summary of the material terms of the Memorandum Amendment and does not purport to be complete and is qualified in its entirety by reference to the Memorandum Amendment, form of which was filed as Exhibit 99.3 to the Company’s Form 6-K filed on May 18, 2026.